A vaccine that may prevent HIV has been given the green light by the U.S. Food and Drug Administration to begin clinical trials in humans, according to Canadian researchers.

The announcement…

Temporary anti-retroviral therapy during the first stage of HIV infection can delay the time to long-term treatment, researchers reported.

In a randomized trial, early treatment reduced the so-called viral set point…

The FDA has expanded the indication for etravirine (Intelence) to include treatment of HIV-1 in pediatric patients ages 6 and older in combination with other anti-retroviral medication.

The expansion means…

A study in this week’s PLoS Medicine suggests that when people are first infected with HIV (primary HIV infection), temporary treatment with antiretroviral drugs (cART)…

Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in…

Mount Sinai School of Medicine researchers have discovered that marijuana-like chemicals trigger receptors on human immune cells that can directly inhibit a type of human immunodeficiency virus (HIV)…

A new research report appearing in the March 2012 issue of the journal Genetics shows why the development of a cure and new treatments for HIV has been…

Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women. Scientists have known for years that traumatized women…

Add one more complication to uncontrolled HIV infection - damaged lungs.

In an observational study, people with uncontrolled HIV infection experienced a loss in lung function at a sharply higher…

HIV patients in the U.S. start treatment earlier than patients elsewhere in the world, according to an analysis of immune system markers presented here.

However, a patient…

More HIV treatment in a community results in fewer new HIV infections, a South African study has revealed.

When HIV treatment coverage reached 20% of the infected population, a surveillance project…

The story of pre-exposure prophylaxis for HIV - using medications to prevent infection - was anything but easy to understand at the Conference on Retroviruses and Opportunistic Infections.

One study…

Scientists, stymied for decades by the complexity of the human immunodeficiency virus, are making progress on several fronts in the search for a cure for HIV infections, a…

A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.

A team of researchers at the University of North Carolina at Chapel Hill has successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma. Tackling…

A new study published on the 9th of March shows that the rate of HIV infections in women living in the epidemic…

An Atlanta research collaboration may be one step closer to finding a vaccine that will provide long-lasting protection against repeated exposures to human immunodeficiency virus (HIV).…

A new set of HIV guidelines urges closer and more personalized monitoring of drug adherence, entry to care, and retention in care.

The 37 recommendations arise from the first effort at synthesizing…

Pre-exposure prophylaxis with antiretroviral drugs failed to prevent women in Africa from becoming infected with human immunodeficiency virus (HIV) – apparently because more than half the women failed to take…

Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of…

Fewer injection drugs users are infected with HIV, but they’re also less likely to have been tested for the virus, according to CDC data.

Interviews and tests in 2009…

HIV infections among intravenous drug users in the United States have fallen by half in the past decade, but HIV testing is also down and risky behaviors such…

Using a mathematical formula that carefully measures the degree to which HIV infection of immune system cells is stalled…

One of the frustrations for scientists working on HIV/AIDS treatments has been the human immunodeficiency virus’ ability to evade the body’s immune system. Now…

Scientists from the Antwerp Institute of Tropical Medicine, Antwerp University Hospital and Antwerp University have tested a new ‘therapeutic vaccine’ against HIV on volunteers. The participants were so to say vaccinated with…